Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aroa Biosurgery Ltd ( (AU:ARX) ) has issued an announcement.
Aroa Biosurgery Ltd announced the cessation of certain securities due to unmet conditions, impacting a total of 2,608,699 securities. This development may affect the company’s capital structure and could have implications for stakeholders regarding the company’s financial strategies and market positioning.
The most recent analyst rating on (AU:ARX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on Aroa Biosurgery Ltd stock, see the AU:ARX Stock Forecast page.
More about Aroa Biosurgery Ltd
Aroa Biosurgery Ltd operates in the biosurgery industry, focusing on developing and manufacturing regenerative tissue products. The company is known for its innovative solutions that aid in healing complex wounds and soft tissue reconstruction, catering primarily to the healthcare sector.
Average Trading Volume: 380,334
Technical Sentiment Signal: Sell
Current Market Cap: A$174.2M
Learn more about ARX stock on TipRanks’ Stock Analysis page.